Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Perrigo Company plc    PRGO   IE00BGH1M568

PERRIGO COMPANY PLC

(PRGO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

PERRIGO COMPANY PLC : Ex-dividend day for

05/28/2020 EST

A dividend is removed today from Perrigo Company plc's share.



© Factset 2020
All news about PERRIGO COMPANY PLC
11/25PERRIGO COMPANY PLC : Ex-dividend day for
FA
11/20PERRIGO : 'Quitting is better' Campaign Enters its Fourth Year of Partnership wi..
AQ
11/13Sol-Gel Technologies Reports Third Quarter 2020 Financial Results and Corpora..
AQ
11/05PERRIGO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
AQ
11/04PERRIGO : 3Q Earnings Snapshot
AQ
11/04PERRIGO CO PLC : Results of Operations and Financial Condition, Financial Statem..
AQ
11/04Perrigo loses bid to quash $1.9 bln Irish back tax demand
RE
11/04Irish High Court rejects Perrigo bid to quash 1.6 bln euro back tax bill
RE
10/28PERRIGO : to Build New North American Corporate Headquarters on 'Medical Mile' i..
AQ
09/18Sensex, Nifty end lower as banks drop; pharma shines
RE
More news
Financials (USD)
Sales 2020 5 123 M - -
Net income 2020 65,6 M - -
Net Debt 2020 2 747 M - -
P/E ratio 2020 74,2x
Yield 2020 1,85%
Capitalization 6 582 M 6 582 M -
EV / Sales 2020 1,82x
EV / Sales 2021 1,72x
Nbr of Employees 11 200
Free-Float 99,3%
Chart PERRIGO COMPANY PLC
Duration : Period :
Perrigo Company plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PERRIGO COMPANY PLC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 54,11 $
Last Close Price 48,22 $
Spread / Highest target 32,7%
Spread / Average Target 12,2%
Spread / Lowest Target -17,0%
EPS Revisions
Managers
NameTitle
Murray S. Kessler President, Chief Executive Officer & Director
Rolf Allan Classon Chairman
Raymond P. Silcock Chief Financial & Accounting Officer
Thomas Farrington Chief Information Officer & Executive VP
Grainne Quinn Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
PERRIGO COMPANY PLC-7.03%6 556
JOHNSON & JOHNSON-1.28%379 086
ROCHE HOLDING AG-3.66%285 972
PFIZER INC.0.30%206 939
NOVARTIS AG-11.80%203 829
MERCK & CO., INC.-12.19%202 049